Marzena Pazgier
Citado por
Citado por
Human β-defensins
M Pazgier, DM Hoover, D Yang, W Lu, J Lubkowski
Cellular and Molecular Life Sciences CMLS 63, 1294-1313, 2006
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
M Pazgier, M Liu, G Zou, W Yuan, C Li, C Li, J Li, J Monbo, D Zella, ...
Proceedings of the National Academy of Sciences 106 (12), 4665-4670, 2009
Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets
H Chu, M Pazgier, G Jung, SP Nuccio, PA Castillo, MF De Jong, ...
Science 337 (6093), 477-481, 2012
D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms
M Liu, C Li, M Pazgier, C Li, Y Mao, Y Lv, B Gu, G Wei, W Yuan, C Zhan, ...
Proceedings of the National Academy of Sciences 107 (32), 14321-14326, 2010
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
I Ullah, J Prévost, MS Ladinsky, H Stone, M Lu, SP Anand, ...
Immunity 54 (9), 2143-2158. e15, 2021
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding
Y Guan, M Pazgier, MM Sajadi, R Kamin-Lewis, S Al-Darmarki, R Flinko, ...
Proceedings of the National Academy of Sciences 110 (1), E69-E78, 2013
Systematic mutational analysis of peptide inhibition of the p53–MDM2/MDMX interactions
C Li, M Pazgier, C Li, W Yuan, M Liu, G Wei, WY Lu, W Lu
Journal of molecular biology 398 (2), 200-213, 2010
Toward understanding the cationicity of defensins: Arg and Lys versus their noncoded analogs
G Zou, E de Leeuw, C Li, M Pazgier, C Li, P Zeng, WY Lu, J Lubkowski, ...
Journal of biological chemistry 282 (27), 19653-19665, 2007
CD4 mimetics sensitize HIV-1-infected cells to ADCC
J Richard, M Veillette, N Brassard, SS Iyer, M Roger, L Martin, M Pazgier, ...
Proceedings of the National Academy of Sciences 112 (20), E2687-E2694, 2015
Through the looking glass, mechanistic insights from enantiomeric human defensins
G Wei, E de Leeuw, M Pazgier, W Yuan, G Zou, J Wang, B Ericksen, ...
Journal of Biological Chemistry 284 (42), 29180-29192, 2009
Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection
P Acharya, WD Tolbert, N Gohain, X Wu, L Yu, T Liu, W Huang, C Huang, ...
Journal of virology 88 (21), 12895-12906, 2014
A left handed solution to peptide inhibition of the p53-MDM2 interaction
M Liu, M Pazgier, C Li, W Yuan, C Li, W Lu
Angewandte Chemie (International ed. in English) 49 (21), 3649, 2010
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
W Li, Y Chen, J Prévost, I Ullah, M Lu, SY Gong, A Tauzin, R Gasser, ...
Cell reports 38 (2), 2022
Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses
J Pollara, M Bonsignori, M Anthony Moody, M Pazgier, B F Haynes, ...
Current HIV research 11 (5), 378-387, 2013
Human defensins: synthesis and structural properties
M Pazgier, X Li, W Lu, J Lubkowski
Current pharmaceutical design 13 (30), 3096-3118, 2007
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection
G Beaudoin-Bussières, Y Chen, I Ullah, J Prévost, WD Tolbert, K Symmes, ...
Cell reports 38 (7), 2022
An asymmetric opening of HIV-1 envelope mediates antibody-dependent cellular cytotoxicity
N Alsahafi, N Bakouche, M Kazemi, J Richard, S Ding, S Bhattacharyya, ...
Cell host & microbe 25 (4), 578-587. e5, 2019
Limitations of peptide retro-inverso isomerization in molecular mimicry
C Li, M Pazgier, J Li, C Li, M Liu, G Zou, Z Li, J Chen, SG Tarasov, WY Lu, ...
Journal of Biological Chemistry 285 (25), 19572-19581, 2010
Studies of the biological properties of human β-defensin 1
M Pazgier, A Prahl, DM Hoover, J Lubkowski
Journal of Biological Chemistry 282 (3), 1819-1829, 2007
Apamin as a novel template for structure-based rational design of potent peptide activators of p53
C Li, M Pazgier, M Liu, WY Lu, W Lu
Angewandte Chemie (International ed. in English) 48 (46), 8712, 2009
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20